Bipartisan ‘Right-To-Try’ Bill Would Keep FDA In The Loop Which May Ease Pharma Worries

The advocates behind the "right-to-try" movement are likely to be upset about the Food and Drug Administration still playing any role, because they think the agency makes the process more cumbersome.

from Kaiser Health News http://ift.tt/2EiNZ59
http://ift.tt/eA8V8J